1045 related articles for article (PubMed ID: 19706802)
1. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.
Dewan MZ; Galloway AE; Kawashima N; Dewyngaert JK; Babb JS; Formenti SC; Demaria S
Clin Cancer Res; 2009 Sep; 15(17):5379-88. PubMed ID: 19706802
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
Demaria S; Kawashima N; Yang AM; Devitt ML; Babb JS; Allison JP; Formenti SC
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):728-34. PubMed ID: 15701862
[TBL] [Abstract][Full Text] [Related]
3. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
Ruocco MG; Pilones KA; Kawashima N; Cammer M; Huang J; Babb JS; Liu M; Formenti SC; Dustin ML; Demaria S
J Clin Invest; 2012 Oct; 122(10):3718-30. PubMed ID: 22945631
[TBL] [Abstract][Full Text] [Related]
4. Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
Pilones KA; Kawashima N; Yang AM; Babb JS; Formenti SC; Demaria S
Clin Cancer Res; 2009 Jan; 15(2):597-606. PubMed ID: 19147765
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models.
Onyshchenko K; Luo R; Rao X; Zhang X; Gaedicke S; Grosu AL; Firat E; Niedermann G
Theranostics; 2024; 14(6):2573-2588. PubMed ID: 38646638
[No Abstract] [Full Text] [Related]
6. Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response.
Habets TH; Oth T; Houben AW; Huijskens MJ; Senden-Gijsbers BL; Schnijderberg MC; Brans B; Dubois LJ; Lambin P; De Saint-Hubert M; Germeraad WT; Tilanus MG; Mottaghy FM; Bos GM; Vanderlocht J
PLoS One; 2016; 11(7):e0159515. PubMed ID: 27427766
[TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
Demaria S; Ng B; Devitt ML; Babb JS; Kawashima N; Liebes L; Formenti SC
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):862-70. PubMed ID: 14967443
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model.
Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S
Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model.
Yoshimoto Y; Suzuki Y; Mimura K; Ando K; Oike T; Sato H; Okonogi N; Maruyama T; Izawa S; Noda SE; Fujii H; Kono K; Nakano T
PLoS One; 2014; 9(3):e92572. PubMed ID: 24686897
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation.
Liu J; Zhou J; Wu M; Hu C; Yang J; Li D; Wu P; Chen Y; Chen P; Lin S; Cui Y; Fu S; Wu J
Front Immunol; 2019; 10():317. PubMed ID: 30873170
[TBL] [Abstract][Full Text] [Related]
11. Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer.
Dewan MZ; Vanpouille-Box C; Kawashima N; DiNapoli S; Babb JS; Formenti SC; Adams S; Demaria S
Clin Cancer Res; 2012 Dec; 18(24):6668-78. PubMed ID: 23048078
[TBL] [Abstract][Full Text] [Related]
12. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model.
Son CH; Bae JH; Shin DY; Lee HR; Choi YJ; Jo WS; Ho Jung M; Kang CD; Yang K; Park YS
J Immunother; 2014 Jan; 37(1):1-7. PubMed ID: 24316550
[TBL] [Abstract][Full Text] [Related]
14. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.
Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817
[TBL] [Abstract][Full Text] [Related]
15. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
[TBL] [Abstract][Full Text] [Related]
17. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models.
Markovsky E; Budhu S; Samstein RM; Li H; Russell J; Zhang Z; Drill E; Bodden C; Chen Q; Powell SN; Merghoub T; Wolchok JD; Humm J; Deasy JO; Haimovitz-Friedman A
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):697-708. PubMed ID: 30342090
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations.
Johnsrud AJ; Jenkins SV; Jamshidi-Parsian A; Quick CM; Galhardo EP; Dings RPM; Vang KB; Narayanasamy G; Makhoul I; Griffin RJ
Radiat Res; 2020 Dec; 194(6):688-697. PubMed ID: 33348372
[TBL] [Abstract][Full Text] [Related]
19. Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model.
Wu L; Wu MO; De la Maza L; Yun Z; Yu J; Zhao Y; Cho J; de Perrot M
Oncotarget; 2015 May; 6(14):12468-80. PubMed ID: 25980578
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.
Hurwitz AA; Yu TF; Leach DR; Allison JP
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10067-71. PubMed ID: 9707601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
